Correlation Between Pfizer and Onconetix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Onconetix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Onconetix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Onconetix, you can compare the effects of market volatilities on Pfizer and Onconetix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Onconetix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Onconetix.

Diversification Opportunities for Pfizer and Onconetix

0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Pfizer and Onconetix is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Onconetix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Onconetix and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Onconetix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Onconetix has no effect on the direction of Pfizer i.e., Pfizer and Onconetix go up and down completely randomly.

Pair Corralation between Pfizer and Onconetix

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.18 times more return on investment than Onconetix. However, Pfizer Inc is 5.52 times less risky than Onconetix. It trades about -0.22 of its potential returns per unit of risk. Onconetix is currently generating about -0.68 per unit of risk. If you would invest  2,808  in Pfizer Inc on August 31, 2024 and sell it today you would lose (225.00) from holding Pfizer Inc or give up 8.01% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Onconetix

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest sluggish performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Onconetix 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Onconetix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pfizer and Onconetix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Onconetix

The main advantage of trading using opposite Pfizer and Onconetix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Onconetix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Onconetix will offset losses from the drop in Onconetix's long position.
The idea behind Pfizer Inc and Onconetix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Fundamental Analysis
View fundamental data based on most recent published financial statements
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges